Literature DB >> 27225301

Connective tissue diseases: Targeting type I interferon in systemic lupus erythematosus.

Timothy B Niewold1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27225301     DOI： 10.1038/nrrheum.2016.83

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Systemic sclerosis and lupus: points in an interferon-mediated continuum.

Authors:  Shervin Assassi; Maureen D Mayes; Frank C Arnett; Pravitt Gourh; Sandeep K Agarwal; Terry A McNearney; Damien Chaussabel; Nancy Oommen; Michael Fischbach; Kairav R Shah; Julio Charles; Virginia Pascual; John D Reveille; Filemon K Tan
Journal:  Arthritis Rheum       Date:  2010-02

2.  Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.

Authors:  Corinna E Weckerle; Beverly S Franek; Jennifer A Kelly; Marissa Kumabe; Rachel A Mikolaitis; Stephanie L Green; Tammy O Utset; Meenakshi Jolly; Judith A James; John B Harley; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2011-04

3.  A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).

Authors:  Kenneth C Kalunian; Joan T Merrill; Romeo Maciuca; Jacqueline M McBride; Michael J Townsend; Xiaohui Wei; John C Davis; William P Kennedy
Journal:  Ann Rheum Dis       Date:  2015-06-02       Impact factor: 19.103

4.  Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.

Authors:  Bernard R Lauwerys; Eric Hachulla; François Spertini; Estibaliz Lazaro; Christian Jorgensen; Xavier Mariette; Edwige Haelterman; Géraldine Grouard-Vogel; Bernard Fanget; Olivier Dhellin; Pierre Vandepapelière; Frédéric A Houssiau
Journal:  Arthritis Rheum       Date:  2013-02

Review 5.  Advances in lupus genetics.

Authors:  Timothy B Niewold
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

Review 6.  Immunological biomarkers in dermatomyositis.

Authors:  Jeannette M Olazagasti; Timothy B Niewold; Ann M Reed
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

7.  Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

Authors:  Tanja Lövgren; Maija-Leena Eloranta; Ullvi Båve; Gunnar V Alm; Lars Rönnblom
Journal:  Arthritis Rheum       Date:  2004-06

8.  Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-α receptor 1 antibody.

Authors:  Li Peng; Vaheh Oganesyan; Herren Wu; William F Dall'Acqua; Melissa M Damschroder
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  Peripheral blood gene expression profiling in Sjögren's syndrome.

Authors:  E S Emamian; J M Leon; C J Lessard; M Grandits; E C Baechler; P M Gaffney; B Segal; N L Rhodus; K L Moser
Journal:  Genes Immun       Date:  2009-04-30       Impact factor: 2.676

10.  Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.

Authors:  Munther Khamashta; Joan T Merrill; Victoria P Werth; Richard Furie; Kenneth Kalunian; Gabor G Illei; Jorn Drappa; Liangwei Wang; Warren Greth
Journal:  Ann Rheum Dis       Date:  2016-03-23       Impact factor: 19.103
  10 in total
  11 in total

1.  Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.

Authors:  Nailú Angélica Sinicato; Mariana Postal; Simone Appenzeller; Timothy B Niewold
Journal:  Pharmaceut Med       Date:  2017-01-25

Review 2.  Type I interferon in rheumatic diseases.

Authors:  Theresa L Wampler Muskardin; Timothy B Niewold
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 3.  Lessons from precision medicine in rheumatology.

Authors:  Theresa L Wampler Muskardin; Jacqueline L Paredes; Simone Appenzeller; Timothy B Niewold
Journal:  Mult Scler       Date:  2020-01-22       Impact factor: 6.312

Review 4.  Type I interferon in the pathogenesis of systemic lupus erythematosus.

Authors:  Mariana Postal; Jessica F Vivaldo; Ruth Fernandez-Ruiz; Jacqueline L Paredes; Simone Appenzeller; Timothy B Niewold
Journal:  Curr Opin Immunol       Date:  2020-11-24       Impact factor: 7.486

5.  FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus.

Authors:  Imene Melki; Isabelle Allaeys; Nicolas Tessandier; Benoit Mailhot; Nathalie Cloutier; Robert A Campbell; Jesse W Rowley; David Salem; Anne Zufferey; Audrée Laroche; Tania Lévesque; Natalie Patey; Joyce Rauch; Christian Lood; Arnaud Droit; Steven E McKenzie; Kellie R Machlus; Matthew T Rondina; Steve Lacroix; Paul R Fortin; Eric Boilard
Journal:  Blood       Date:  2020-12-17       Impact factor: 22.113

6.  Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients.

Authors:  Barbara Detrick; Sapna Gangaputra; Doreen N Palsgrove; Christopher D Heaney; John J Hooks; H Nida Sen
Journal:  J Neuroimmunol       Date:  2017-12-29       Impact factor: 3.478

7.  Insights from deconvolution of cell subtype proportions enhance the interpretation of functional genomic data.

Authors:  Yu Kong; Deepa Rastogi; Cathal Seoighe; John M Greally; Masako Suzuki
Journal:  PLoS One       Date:  2019-04-25       Impact factor: 3.240

8.  Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus.

Authors:  Uma Thanarajasingam; Anoohya N Muppirala; Mark A Jensen; Yogita Ghodke-Puranik; Jessica M Dorschner; Danielle M Vsetecka; Shreyasee Amin; Ashima Makol; Floranne Ernste; Thomas Osborn; Kevin Moder; Vaidehi Chowdhary; Timothy B Niewold
Journal:  ACR Open Rheumatol       Date:  2019-08-19

9.  Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus.

Authors:  Nils Venhoff; Ulrich A Walker; Stavros Giaglis; Douglas Daoudlarian; Reinhard E Voll; Diego Kyburz
Journal:  RMD Open       Date:  2021-12

10.  Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren's syndrome.

Authors:  Albin Björk; Elina Richardsdotter Andersson; Juliana Imgenberg-Kreuz; Gudny Ella Thorlacius; Johannes Mofors; Ann-Christine Syvänen; Marika Kvarnström; Gunnel Nordmark; Marie Wahren-Herlenius
Journal:  RMD Open       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.